Tolerability and acute safety of AdMSC infusion by assessment of the total number of AEs/SAEs related and non-related with the medication;The overall proportion of subjects who develop any AEs/SAEs related and non-related with the AdMSC infusions as compared to the control group;COVID-19 incidence rates in both the study and control groups

Tolerability and acute safety of AdMSC infusion by assessment of the total number of AEs/SAEs related and non-related with the medication;The overall proportion of subjects who develop any AEs/SAEs related and non-related with the AdMSC infusions as compared to the control group;COVID-19 incidence rates in both the study and control groups